Adjuvant Anal Imiquimod Therapy in Anal HPV-lesions: AdAM-trial

Clinical trial NCT03289260 · UNKNOWN

Trial details

NCT number: NCT03289260
Sponsor: Medical University Innsbruck
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Anogenital Human Papillomavirus Infection Condyloma Anal

Start date: 2021-11-15
Primary completion: 2024-11-15
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.